With the analysis among 916 patents, we discovered top 288 key players by total patent application. C4 Therapeutics, Inc., Jiangxi Jemincare Group Co., Ltd., Shanghai Jiyu Pharmaceutical Technology Co Ltd are dominant in this area. They take 24.34% of the total patent filing.
Massachusetts, United States
Patent: 32
Jiangxi Jemincare Group Co., Ltd.
Jiangxi Sheng, China
Patent: 22
Shanghai Jiyu Pharmaceutical Technology Co Ltd
Shanghai Shi, China
Patent: 22
Mitsubishi Tanabe Pharma Corp.
Osaka-fu, Japan
Patent: 18
Hinova Pharmaceuticals, Inc.
Sichuan Sheng, China
Patent: 16
Basel-Stadt, Switzerland
Patent: 15
California, United States
Patent: 12
Kymera Therapeutics, Inc.
Massachusetts, United States
Patent: 11
F. Hoffmann-La Roche Ltd.
With the analysis among 51 patents, we discovered top 14 start-ups by total patent application. Orionis Biosciences, Inc., Nuritas Ltd., Ribon Therapeutics, Inc. are active in this area.
Orionis Biosciences, Inc.
Massachusetts, United States
Patent: 10
Massachusetts, United States
Patent: 7
Kanagawa-ken, Japan
Patent: 6
Institut National de la Santé et de la Recherche Médicale
Washington, United States
Patent: 4
California, United States
Patent: 3
Washington, United States
Patent: 2
ZURICH, Switzerland
Patent: 2
With the analysis among related 727 patents applied in the last 5 years. We discover 293 most active companies in this area. The fast-growing Dana-Farber Cancer Institute, Inc., C4 Therapeutics, Inc., Jiangxi Jemincare Group Co., Ltd. take 18.57% of patent filing during this period.
Dana-Farber Cancer Institute, Inc.
Massachusetts, United States
Patent: 81
Massachusetts, United States
Patent: 32
Jiangxi Jemincare Group Co., Ltd.
Jiangxi Sheng, China
Patent: 22
Shanghai Jiyu Pharmaceutical Technology Co Ltd
Shanghai Shi, China
Patent: 22
Mitsubishi Tanabe Pharma Corp.
Osaka-fu, Japan
Patent: 18
Shanghai Shi, China
Patent: 17
Hinova Pharmaceuticals, Inc.
Sichuan Sheng, China
Patent: 15
Basel-Stadt, Switzerland
Patent: 14
Regents of the University of California
California, United States
Patent: 11
Kymera Therapeutics, Inc.
Massachusetts, United States
Patent: 11
With the analysis among related 727 patents in last 5 years, we discover 250 new entrants. C4 Therapeutics, Inc., Jiangxi Jemincare Group Co., Ltd., Shanghai Jiyu Pharmaceutical Technology Co Ltd are the most active new entrants in this area.
Massachusetts, United States
Patent: 32
Jiangxi Jemincare Group Co., Ltd.
Jiangxi Sheng, China
Patent: 22
Shanghai Jiyu Pharmaceutical Technology Co Ltd
Shanghai Shi, China
Patent: 22
Mitsubishi Tanabe Pharma Corp.
Osaka-fu, Japan
Patent: 18
Shanghai Shi, China
Patent: 17
Kymera Therapeutics, Inc.
Massachusetts, United States
Patent: 11
Orionis Biosciences, Inc.
Massachusetts, United States
Patent: 10
Massachusetts, United States
Patent: 7
Washington, United States
Patent: 7
With the analysis among 434 patents, we discovered top 118 universities and scientific research institutions by total patent application. President & Fellows of Harvard College, Shanghaitech University, Yale University are dominant in this area. They take 17.97% of the total patent filing.
President & Fellows of Harvard College
Massachusetts, United States
Patent: 35
Shanghai Shi, China
Patent: 17
Connecticut, United States
Patent: 12
China Pharmaceutical University
Jiangsu Sheng, China
Patent: 9
Korea Advanced Institute of Science & Technology
Washington, United States
Patent: 7
Massachusetts Institute of Technology
Massachusetts, United States
Patent: 7
Miyagi-ken, Japan
Patent: 7
Massachusetts, United States
Patent: 6
Xi'an Jiaotong University
Shaanxi Sheng, China
Patent: 6